by experienced scientists and executives.
We are currently evaluating and developing products
at different stages of development, both clinical and preclinical.
Who are we?
Neurofix is a Spanish biotech company founded in 2015, focused on drug research and development.
Since its inception in 2015, Neurofix Pharma has received support and recognition from various institutions to promote its project. It is worth highlighting the award of seals such as ‘Best Company NEOTEC line’, ‘Innovative SME’ and ‘EU Horizon 2020 Excellence’, in addition to the support of Enisa, Iberaval, CDTI, ICO and European SME, among others. The company also has important investors, including the Matutes family office.
Where do we come from?
Over the past few years, Neurofix has achieved significant milestones in the various phases of pre-clinical and clinical trials, culminating in the successful completion of Phase IIA.
Actualidad Neurofix
ACTUALIDAD NEUROFIX
Neurofix Pharma will participate in the major biotechnology events.24 de August de 2023 - 13:33
Neurofix Pharma presents the successful results of its phase IIA clinical trial to institutions and businessmen in Salamanca28 de November de 2022 - 08:46
Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial11 de November de 2022 - 15:42